LivaNova PLC Ordinary Shares (LIVN) is a publicly traded Healthcare sector company. As of May 21, 2026, LIVN trades at $73.56 with a market cap of $3.97B and a P/E ratio of -16.53. LIVN moved +1.08% today. Year to date, LIVN is +16.57%; over the trailing twelve months it is +64.24%. Its 52-week range spans $32.48 to $74.32. Analyst consensus is buy with an average price target of $80.00. Rallies surfaces LIVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading LIVN stock inside the company?
Recent LIVN insider activity includes Story Brooke sold 250, Bianchi Francesco sold 1.50K, Bianchi Francesco sold 1.25K, and Bianchi Francesco sold 1.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
LIVN Key Metrics
Key financial metrics for LIVN
Metric
Value
Price
$73.56
Market Cap
$3.97B
P/E Ratio
-16.53
EPS
$-4.45
Dividend Yield
0.00%
52-Week High
$74.32
52-Week Low
$32.48
Volume
234
Avg Volume
0
Revenue (TTM)
$1.39B
Net Income
$-242.47M
Gross Margin
67.71%
Recent LIVN Insider Trades
Story Brooke sold 250 (~$13.48K) on Nov 18, 2025.
Bianchi Francesco sold 1.50K (~$84.75K) on Aug 25, 2025.
Bianchi Francesco sold 1.25K (~$63.74K) on Dec 11, 2024.
Bianchi Francesco sold 1.50K (~$69.87K) on Sep 11, 2024.
Recent LIVN insider activity includes Story Brooke sold 250, Bianchi Francesco sold 1.50K, Bianchi Francesco sold 1.25K, and Bianchi Francesco sold 1.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for LIVN?
Yes. Rallies tracks LIVN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is LIVN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for LIVN. It does not provide personalized investment advice.
